Search results
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
Digital Journal· 7 days agoThe team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare neurological conditions ...
Larry Magid: Hearing aids are cool now
San Jose Mercury News· 5 days agoWhen I was a child, I couldn’t help noticing my grandfather’s large, flesh-colored hearing aids, but this weekend I sat across from a friend and didn’t...
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific...
Benzinga· 6 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
...R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma...
Benzinga· 6 days agoSIPP Industries, Inc. SIPC, a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce ...
Can Adderall Help With My Anxiety?
AOL· 3 days agoAdderall is a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This mental health condition can make it tough to focus and is characterized by feelings of impulsivity ...
3 Healthcare Dividend Stocks to Buy Now
TheStreet.com· 2 days agoThe healthcare sector offers an opportunity for long-term growth and dividends, with these three companies at the top of our list. The U.S. healthcare...
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To...
The Joplin Globe· 5 days agoTORONTO, ON / ACCESSWIRE / June 13, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ...
Biophytis Announces the Successful Industrial Transfer of BIO101
Digital Journal· 6 days agoBIO101 (20-hydroxyecdysone), our lead drug candidate, is a small molecule in development for muscular (sarcopenia, phase 3 ready and Duchenne muscular dystrophy), respiratory ...
HAIR SUPPLEMENTS: ARE THEY WORTH THE HYPE? ISHRS HAIR RESTORATION EXPERTS EXAMINE THE SCIENCE BEHIND...
The Parsons Sun· 4 days agoDespite the glowing testimonials from consumers in advertisements promoting hair supplements to combat hair loss and thinning, hair restoration experts warn that consuming supplements without ...
Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue...
Digital Journal· 5 days agoCosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale ...
